EGFR and neoplasm: In contrast, inhibition of EGFR signaling by gefitinib, an EGFR kinase inhibitor, inhibitspomc expression in mice and corticotroph cell proliferation in cell cultures, decreasing tumor growth and cortisol levels with improvement of clinical features64.